Trinity Biotech (TRIB) EBITDA Margin (2009 - 2024)
Trinity Biotech (TRIB) posted EBITDA Margin of 72.61% for Q4 2024, down 330.07% sequentially from 16.88% in Q3 2024, and down 4446.0% YoY from 1.67% in Q1 2024.
Trinity Biotech (TRIB) EBITDA Margin (2009 - 2024) Analysis & Trends
Trinity Biotech has reported EBITDA Margin for 16 years, with the latest figure at 72.61% in Q4 2024.
- Quarterly EBITDA Margin fell 4446.0% year-over-year to 72.61% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 34.38% (up 1321.0% YoY) and the FY2025 annual result came in at 36.06%, down 168.0% from the prior year.
- EBITDA Margin slipped to 72.61% in Q4 2024 per TRIB's latest filing, from 16.88% in the prior quarter.
- Over five years, EBITDA Margin peaked at 28.38% in Q3 2020 and troughed at 106.86% in Q2 2023.
- A 5-year average of 17.79% and a median of 14.44% in 2022 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin sank 9486 bps in 2023, then jumped 8129 bps in 2024.
- Over 5 years, EBITDA Margin stood at 27.67% in 2020, then tumbled by 90 bps to 2.88% in 2021, then slumped by 1899 bps to 51.87% in 2022, then soared by 46 bps to 28.14% in 2023, then sank by 158 bps to 72.61% in 2024.
- According to Business Quant data, EBITDA Margin over the past three periods registered 72.61%, 16.88%, and 25.58% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | Trinity Biotech | 6.45 Mn | 1.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -72.61% |
| Sep 30, 2024 | -16.88% |
| Jun 30, 2024 | -25.58% |
| Mar 31, 2024 | -20.68% |
| Dec 31, 2023 | -28.14% |
| Sep 30, 2023 | -30.66% |
| Jun 30, 2023 | -106.86% |
| Mar 31, 2023 | -26.43% |
| Dec 31, 2022 | -51.87% |
| Sep 30, 2022 | -51.78% |
| Jun 30, 2022 | -12.00% |
| Mar 31, 2022 | -7.76% |
| Dec 31, 2021 | 2.88% |
| Sep 30, 2021 | 12.58% |
| Jun 30, 2021 | 0.84% |
| Mar 31, 2021 | 12.03% |
| Dec 31, 2020 | 27.67% |
| Sep 30, 2020 | 28.38% |
| Jun 30, 2020 | 3.13% |
| Mar 31, 2020 | 7.99% |